ATCC is excited to launch their 2025 Innovation Challenge, inviting researchers to explore bold, creative applications of their ThawReady™ Assay Ready Cells, an innovative line of products designed to accelerate cell-based assays and eliminate the need for lengthy cell expansion and banking prior to starting bioassays, saving valuable time and money.
Running through November 30, 2025, the challenge offers researchers an opportunity to win free ThawReady™ products and gain visibility through collaboration with ATCC in webinars, conference showcases, and other scientific platforms. To enter, researchers must submit a short proposal (up to 1000 characters) describing how they plan to use ThawReady™ cells in their innovative research. Winning entries will receive complimentary products and the opportunity to share their work with the broader scientific community.
Two models are available for the challenge:
- Derived from a human monocytic leukemia patient.
- Ideal for immunology, toxicology, and cancer research.
- Supports assays such as monocyte differentiation, phagocytosis, and co-culture studies.
- Preserved in a chemically defined, animal-free formulation.
- Ready to use upon thawing with ≥80% viability.
ThawReady™ THP-1 NF-κB-Luc2 (TIB-202-NFkB-LUC2-AR)
- Engineered to express luciferase under NF-κB control.
- Enables sensitive, quantitative analysis of NF-κB activation.
- Demonstrates over 200-fold increase in luminescence upon LPS stimulation.
- Maintains functionality and morphology post-thaw, even after extended rest periods.
- Suitable for drug screening, pathway analysis, and biocompatibility testing.